awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36952837-CF04ACE0-C8DA-4536-B88D-D63C5CB49871
Q36952837-CF04ACE0-C8DA-4536-B88D-D63C5CB49871
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36952837-CF04ACE0-C8DA-4536-B88D-D63C5CB49871
Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.
P2860
Q36952837-CF04ACE0-C8DA-4536-B88D-D63C5CB49871
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36952837-CF04ACE0-C8DA-4536-B88D-D63C5CB49871
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1c2429fc5c24e613c8559bc04e71198f63fc40e5
P2860
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.